As the new variants of Covid-19 continue to spread across Malaysia, many would have concerns on whether the vaccines gives is sufficient protection against them.
Responding to that matter, the Coordinating Minister of the National COVID-19 Immunization Program (PICK), Khairy Jamaluddin said that they will discuss about this in the Special Committee on COVID-19 Vaccine Supply (JKJAV) meeting next week.
He added that a group of experts will present some recommendations on whether a third dose or booster shot of COVID-19 vaccine is required at the meeting. In addition, Khairy said that they will discuss about the distribution of the vaccines of other brands too.
“I understand, a group of experts will make some recommendations regarding the booster shot or the third dose and this also has to do with the administration of different vaccines.” he said in a press conference attended by Astro Awani.
Previously, the government had been studying the effectiveness of the current vaccines on COVID-19 cases involving the Delta variant and the need for a third injection of the vaccine.
He also mentioned that the matter obviously requires discussion as other countries are still considering whether a third dose should be given.
“Other countries have not yet made a decision, there are only one, or two countries that have given the impression that they will give a third dose.”
“For example in the UAE and some Middle Eastern countries, they are recommended for Pfizer to those who complete two doses of the vaccine.” he said.
On the other hand, according to Business Insider, Dr. Anthony Fauci, the top US infectious-disease expert says that a booster shot might likely happen after they examined the preliminary data from Israel.
The data from Israel suggests that the efficacy rate of the Pfizer-BioNTech vaccine in protecting people against infection might have dropped amid the spread of the Delta variant.
It is revealed that the new data shows that the Pfizer vaccine was just 39% effective at preventing nationwide infections in late June and early July, despite having a 95% efficacy rate from January to early April.
Nonetheless, it is still 90% effective at preventing severe infection and hospitalisation.
Stay tuned for more updates regarding the booster shot.